Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at SGD 121.5B, ahead of Eli Lilly (SGD 84.1B) and Merck & Co (SGD 83.9B). Figures as of 20 Nov 2026, 22:54 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonSGD 121.5B
- Median
- SGD 1.8B
- Combined market value
- SGD 4.82T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SGD 121.5B | SGD 839.9B | SGD 348.91 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | SGD 84.1B | SGD 1.55T | SGD 1,737.77 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | SGD 83.9B | SGD 425.3B | SGD 172.50 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | SGD 80.7B | SGD 201.5B | SGD 35.35 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | SGD 78.9B | SGD 652.6B | SGD 369.20 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SGD 62.2B | SGD 155B | SGD 75.85 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | SGD 57.2B | SGD 230.1B | SGD 132.87 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | SGD 18.5B | SGD 122.9B | SGD 1,187.69 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | SGD 18.4B | SGD 29B | SGD 25.32 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | SGD 15.5B | SGD 168.4B | SGD 664.38 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | SGD 12.2B | SGD 41.5B | SGD 102.05 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | SGD 6.1B | SGD 16.6B | SGD 33.20 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | SGD 4.8B | SGD 24.8B | SGD 185.53 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | SGD 4.2B | SGD 15.1B | SGD 77.93 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | SGD 4.1B | SGD 30.5B | SGD 715.60 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | SGD 3.9B | SGD 9.5B | SGD 27.24 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | SGD 3.1B | SGD 50.8B | SGD 88.30 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | SGD 2.2B | SGD 6.1B | SGD 72.78 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 3.8B | SGD 19.67 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.2B | SGD 11.4B | SGD 489.04 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | SGD 1.2B | SGD 5.7B | SGD 34.29 | 2.35% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.5B | SGD 53.37 | 5.22% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | SGD 982.2M | SGD 9B | SGD 82.07 | 2.09% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | SGD 823.7M | SGD 8.8B | SGD 166.87 | 4.66% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | SGD 795M | SGD 12.4B | SGD 81.71 | 2.37% down | 103% up | ||
| 26 | InsmedINSM · Health Care | SGD 782.3M | SGD 40B | SGD 182.32 | 2.17% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | SGD 672.5M | SGD 8.1B | SGD 124.01 | 0.65% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | SGD 647.7M | SGD 19.1B | SGD 98.08 | 2.75% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | SGD 633M | SGD 5.8B | SGD 60.63 | 2.69% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | SGD 345.8M | SGD 7.4B | SGD 370.04 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 244.8M | SGD 10B | SGD 144.94 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | SGD 113.6M | SGD 9.1B | SGD 65.51 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | SGD 59.4M | SGD 10.2B | SGD 156.61 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | SGD 2.6M | SGD 6.1B | SGD 109.07 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | SGD 0 | SGD 11.5B | SGD 120.58 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | SGD 0 | SGD 10.8B | SGD 387.55 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2900 SGD). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (SGD 121.5B), Eli Lilly (SGD 84.1B) and Merck & Co (SGD 83.9B) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 22:54 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of SGD 4.82T as of 20 Nov 2026, 22:54 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.